BioSig Technologies to Present at the Drexel Hamilton Micro Cap Investor Forum

BioSig Technologies (OTCQB:BSGM), a medical device company developing the PURE EP System, a proprietary platform designed to improve the clinical outcomes of electrophysiology procedures, today announced that the company will present at the Drexel Hamilton Micro Cap Investor Forum held on May 12, 2016 at Drexel Hamilton’s office at 77 Water Street, Second Floor in Lower Manhattan.
The event will bring together institutional investors and emerging, high growth-potential companies. Institutional investors will have the opportunity to learn more about each of the 50 companies highlighted at the event. The conference will provide companies with a 30-minute time slot to present to an audience of investors and industry professionals. Management will also be available for one-on-one meetings with institutional investors.
BioSig Technologies is scheduled to present at 11:30am ET in Track C. During the presentation, Kenneth Londoner, BioSig Executive Chairman will update the investment community on the Company’s recent operational achievements as well as objectives for the next twelve months. To arrange a one-on-one meeting, please contact Brian McLaughlin, VP of Corporate Finance and Investor Relations at bmclaughlin@biosigtech.com or call (917) 370-9817.
Connect with BioSig Technologies (OTCQB:BSGM) to receive an Investor Presentation.